Klin Farmakol Farm. 2011;25(2):72-75

Vitamin D

Václav Vyskočil
Fakultní nemocnice Plzeň, II. interní klinika, Osteocentrum Plzeň

The author describes the metabolism of vitamin D and the mechanism of its action in the body, while paying attention not only to skeletal

but also to non-skeletal effects of vitamin D, ie. effect on the immune system and affecting of the autoimmune and cancer diseases. In

a similar way, author examines the active metabolite, which, unlike the classical vitamin D has the effect not only in the absence of the

substance in the body, but even at its normal levels, especially in terms of muscle strength, coordination and interference of the speed

of neuromuscle transmission.

Keywords: vitamin D, osteoporosis, deficiency

Published: June 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vyskočil V. Vitamin D. Klin Farmakol Farm. 2011;25(2):72-75.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vyskočil V. Osteoporóza a ostatní nejčastější metabolická onemocnění skeletu. Praha: Galén, 2009: 507.
    2. Armas LAG, Hollis BW, Heaney RP. Vitamin D2 is much less effective than Vitamin D3 in Humans. J Clin Endocrinol Metab 2004; 89(11): 5387-5391. Go to original source... Go to PubMed...
    3. Carlton S, Clopton D, Cappuzzo KA. Vitamin D Deficiency: Appropriate Replenishment Therapies and the Effects of Vitamin D Toxicity. The Consultant Pharmacist 2010; 25(3): 171-177. Go to original source... Go to PubMed...
    4. Vieth R. Vitamin D supplementation, 25-hydrocyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-856. Go to original source... Go to PubMed...
    5. Gertner JM, Domenech M. 25-hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol. Clin Pathol 1977; 30: 144-150. Go to original source... Go to PubMed...
    6. Mawer EB, Hann JT, Berry JL, Davies M. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 1985; 68: 135-141. Go to original source... Go to PubMed...
    7. Rizzoli R. Stoermann C, Ammann P, Bonjour JP. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy. Bone 1994; 15: 193-198. Go to original source... Go to PubMed...
    8. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327(23): 1637-1642. Go to original source... Go to PubMed...
    9. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial BMJ. 2003; 326(7387): 469. Go to original source... Go to PubMed...
    10. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007; 92(4): 1415-1423. Go to original source... Go to PubMed...
    11. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Ditrich T and Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28. Go to original source... Go to PubMed...
    12. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009; 339: b3692. Go to original source... Go to PubMed...
    13. Heaney RP, Dowell MS, Hale CA, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003; 22(2): 142-146. Go to original source... Go to PubMed...
    14. Heaney RP. Vitamin D depletion and effective calcium absorption. J Bone Miner Res 2003; 18(7): 1342; author reply 1343. Go to original source... Go to PubMed...
    15. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337(10): 670-676. Go to original source... Go to PubMed...
    16. Harwood RH, Sahota O, Gaynor K, et al. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 2004; 33(1): 45-51. Go to original source... Go to PubMed...
    17. Bischoff-Ferrari HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. Feb 2003; 18(2): 343-351. Go to original source... Go to PubMed...
    18. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85(6): 1586-1591. Go to original source... Go to PubMed...
    19. Chen TC, Holick MF. Vitamin D and prostate cancer prevention and treatment. Trends Endocrinol Metab 2003; 14(9): 423-430. Go to original source... Go to PubMed...
    20. Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989; 2(8673): 1176-1178. Go to original source... Go to PubMed...
    21. Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci 1999; 889: 107-119. Go to original source... Go to PubMed...
    22. Garland FC, Garland CF, Gorham ED, et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990; 19(6): 614-622. Go to original source... Go to PubMed...
    23. Chen TC, Wang L, Whitlatch LW, et al. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J Cell Biochem 2003; 88(2): 315-322. Go to original source... Go to PubMed...
    24. Freedman DM, Rajaraman P, Fuhrman B, et al. Sunlight, hormone replacement status and colorectal cancer risk in post-menopausal women. Int J Cancer. 2009; 126(8): 1997-2001. Go to original source... Go to PubMed...
    25. Tangpricha V, Flanagan JN, Whitlatch LW, et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 2001; 357(9269): 1673-1674. Go to original source... Go to PubMed...
    26. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia 2005; 48(7): 1247-1257. Go to original source... Go to PubMed...
    27. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. Mar 2004; 79(3): 362-371. Go to original source... Go to PubMed...
    28. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20(7): 713-719. Go to original source... Go to PubMed...
    29. Snijder M, van Dam R, Visser M, et al. Vitamin D and diabetes. Diabetologia 2006; 49: 217-218. Go to original source... Go to PubMed...
    30. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7(5): 439-443. Go to original source... Go to PubMed...
    31. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D and solar ultraviolet. Lancet 1989; ii: 1104-1105. Go to original source... Go to PubMed...
    32. Price PA, Buckley JR and Williamson KM. The Amino Bisphosphonate Ibandronate Prevents Vitamin D Toxicity and Inhibits Vitamin D-Induced Calcification of Arteries, Cartilage, Lungs and Kidneys in Rats. J Nutr 2001; 131: 2910-2915. Go to original source... Go to PubMed...
    33. Rauch F and Rittweger J. What is new in neuro-musculoskeletal interactions? J Musculoskelet Neuronal Interact 2005; 5(1): 91-94.
    34. Skácelová S. Význam vitaminu D pro lidské zdraví. Čes Revmatol 2010; 18(1): 26-40.
    35. Endo I, Inoue D, Mitsumi I. Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors. Endocrinology 144(12): 5138-5144.
    36. Ringe J, Schacht E. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int 2004; 24: 189-197. Go to original source... Go to PubMed...
    37. Li YC. Vitamin D regulation of the renin - angiotensin system. J Cell Biochem 2003; 88: 327-331. Go to original source... Go to PubMed...
    38. Zittermann A, et al. Low Vitamin D Status: a Contributing Factor in the Pathogenesis of Congestive Heart Failure? J Am Coll Cardiol 2003: 41(1). Go to original source... Go to PubMed...
    39. Haschek WM, Krook L, Kallfelz FA, Pond WG. Vitamin D toxicity. Initial site and mode of action. Cornell Vet 1978; 68(3): 324-364. Go to PubMed...
    40. DeLuca FH, Prahl JM, Plum LA. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Archives of Biochemistry and Biophysic 2011; 505: 226-230. Go to original source... Go to PubMed...
    41. Oleson CHV, Patel PH, Wuermser LA. Influence of Season, Ethnicity, and Chronicity on Vitamin D Deficiency in Traumatic Spinal Cord Injury. J Spinal Cord Med 2010; 33(3): 202-213. Go to original source... Go to PubMed...
    42. Food and Nutrition. Vitamin D and Kalcium: Updated Dietary Reference Intakes. http://www.hc-sc.gc.ca/fn-an/nutrition/vitamin/vita-d-eng.php.
    43. Matsuoka M, Otsuka H, Masuda S, et al. Changes in the concentrations of vitamin D and its metabolites in the plasma of healthy subjects orally given physiological doses of vitamin D2 by multivitamin or vitamin D preparations. J Nutr Sci Vitaminol 1989; 35(4): 253-266. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.